Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.76 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.73 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.73 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.73 |
| ▸ | RECQL | P46063 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.63 |
| ▸ | PRKCA | P17252 | 2/20 | 0.59 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.59 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.59 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.59 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.58 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.58 |
| ▸ | PTAFR | P25105 | 1/20 | 0.58 |
| ▸ | HTR1D | P28221 | 1/20 | 0.58 |
| ▸ | HTR2C | P28335 | 1/20 | 0.58 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.58 |
| ▸ | DRD3 | P35462 | 1/20 | 0.58 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29410678 | 1.00 | ALDH1A1 (0.76) | ALDH1A1SMN1; SMN2NR5A2NR5A1RECQL | |
| SCHEMBL30652061 | 1.00 | ALDH1A1 (0.76) | ALDH1A1SMN1; SMN2NR5A2NR5A1RECQL | |
| SCHEMBL3403745 | 1.00 | ALDH1A1 (0.76) | ALDH1A1SMN1; SMN2NR5A2NR5A1RECQL | |
| SCHEMBL3410573 | 1.00 | ALDH1A1 (0.76) | ALDH1A1SMN1; SMN2NR5A2NR5A1RECQL | |
| SCHEMBL3406019 | 1.00 | ALDH1A1 (0.76) | ALDH1A1SMN1; SMN2NR5A2NR5A1RECQL | |
| SCHEMBL3407855 | 1.00 | ALDH1A1 (0.76) | ALDH1A1SMN1; SMN2NR5A2NR5A1RECQL | |
| SCHEMBL753300 | 1.00 | ALDH1A1 (0.76) | ALDH1A1SMN1; SMN2NR5A2NR5A1RECQL | |
| SCHEMBL3405833 | 1.00 | ALDH1A1 (0.76) | ALDH1A1SMN1; SMN2NR5A2NR5A1RECQL | |
| SCHEMBL5053766 | 1.00 | ALDH1A1 (0.76) | ALDH1A1SMN1; SMN2NR5A2NR5A1RECQL | |
| SCHEMBL30521870 | 1.00 | ALDH1A1 (0.76) | ALDH1A1SMN1; SMN2NR5A2NR5A1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020102297-A1 | Macromolecule-lipid complexes and methods for making and using | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2002-08-01 | — | — | US | claimed |
| WO-2000000033-A1 | MACROMOLECULE-LIPID COMPLEXES AND METHODS FOR MAKING AND USING | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-01-06 | — | — | WO | claimed |
| WO-2010126319-A2 | LIPOPEPTIDE WITH SPECIFIC AFFINITY TO THE FC REGION OF AN ANTIBODY, AND ANTIGEN-RECOGNIZING LIPID NANOPARTICLE COMPRISING SAME | 고려대학교 산학협력단 (KR) | 2010-11-04 | — | — | WO | disclosed |
| US-20090226527-A1 | Particulate-stabilized injectable pharmacutical compositions of posaconazole | WITCHEY-LAKSHMANAN LEONORE | 2009-09-10 | — | — | US | disclosed |
| EP-1761247-A1 | INJECTABLE PHARMACEUTICAL SUSPENSION COMPRISING POSACONAZOLE | SCHERING CORPORATION (US) | 2007-03-14 | — | — | EP | disclosed |
| US-20060160823-A1 | Particulate-stabilized injectable pharmaceutical compositions of Posaconazole | SCHERING CORPORATION | 2006-07-20 | — | — | US | disclosed |
| WO-2005117831-A1 | INJECTABLE PHARMACEUTICAL SUSPENSION COMPRISING POSACONAZOLE | SCHERING CORPORATION (US) | 2005-12-15 | — | — | WO | disclosed |
| US-6899895-B2 | Lamellar gels and methods for making and regulating | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-05-31 | — | — | US | disclosed |
| EP-0958380-A4 | MACROMOLECULE-LIPID COMPLEXES AND METHODS FOR MAKING AND USING | UNIV CALIFORNIA (US) | 2004-03-17 | — | — | EP | disclosed |
| US-20020102297-A1 | Macromolecule-lipid complexes and methods for making and using | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2002-08-01 | — | — | US | disclosed |
| US-6358523-B1 | SELECTING A CHARGED MACROMOLECULE; SELECTING A CHARGED LIPID COMBINATION; THE CHARGE OF THE LIPID COMBINATION BEING OPPOSITE OF THE CHARGE OF THE MACROMOLECULE; COMBINING THE MACROMOLECULE WITH THE LIPID COMBINATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2002-03-19 | — | — | US | disclosed |
| US-20010012520-A1 | Lamellar gels and methods for making and regulating | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2001-08-09 | — | — | US | disclosed |
| US-6207186-B1 | CALIBRATION, CONTROLLING STRUCTURE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2001-03-27 | — | — | US | disclosed |
| WO-2000000033-A1 | MACROMOLECULE-LIPID COMPLEXES AND METHODS FOR MAKING AND USING | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-01-06 | — | — | WO | disclosed |
| EP-0958380-A1 | MACROMOLECULE-LIPID COMPLEXES AND METHODS FOR MAKING AND USING | The Regents of The University of California (US) | 1999-11-24 | — | — | EP | disclosed |
| WO-1998035828-A9 | LAMELLAR GELS AND METHODS FOR MAKING AND REGULATING | — | 1999-02-04 | — | — | WO | disclosed |
| WO-1998024936-A9 | MACROMOLECULE-LIPID COMPLEXES AND METHODS FOR MAKING AND USING | — | 1998-10-01 | — | — | WO | disclosed |
| WO-1998035828-A1 | LAMELLAR GELS AND METHODS FOR MAKING AND REGULATING | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-08-20 | — | — | WO | disclosed |
| WO-1998024936-A1 | MACROMOLECULE-LIPID COMPLEXES AND METHODS FOR MAKING AND USING | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-06-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090226527-A1 | Particulate-stabilized injectable pharmacutical compositions of posaconazole | CYP3A7, UGT2B7, UGT1A7 | ALDH1A1 1571/4885SMN1; SMN2 3451/4885NR5A2 1685/4885 |
| US-20060160823-A1 | Particulate-stabilized injectable pharmaceutical compositions of Posaconazole | ERG28, CPSF7, CYP3A5 | ALDH1A1 2131/4885SMN1; SMN2 3156/4885NR5A2 1678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.